Folic acid and homocysteine in age-related disease

Ageing Research Reviews

Volumn 1, Issue 1, 2002, Pages 95-111

  Mattson, Mark P ^a,b   Kruman, Inna I ^a   Duan, Wenzhen ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA repair; Folate deficiency; Homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE;

AGING; CANCER; CARBON METABOLISM; CARDIOVASCULAR DISEASE; CELL DEATH; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DNA DAMAGE; DNA REPAIR; FOLIC ACID DEFICIENCY; GERIATRIC DISORDER; HUMAN; MENTAL DISEASE; MITOSIS; NERVE CELL; REVIEW; STROKE; AGED; CEREBROVASCULAR ACCIDENT; CONGENITAL MALFORMATION; FEMALE; MALE; METABOLISM; NEOPLASM; PATHOLOGY;

ABNORMALITIES; AGED; AGING; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; MALE; MENTAL DISORDERS; NEOPLASMS; NEURODEGENERATIVE DISEASES;

EID: 0036484629     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00365-7     Document Type: Review

References (97)

1. Abou-Saleh M.T., Coppen A. Serum and red blood cell folate in depression. Acta Psychiatry Scand. 80:1989;78-82.
2. Ambrosch A., Dierkes J., Lobmann R., Kuhne W., Konig W., Luley C., Lehnert H. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diab. Med. 18:2001;185-192.
3. Bailey L.B., Wagner P.A., Christakis G.J. Folacin and iron status and hematological findings in black and Spanish-American adolescents from urban low-income households. Am. J. Clin. Nutr. 35:1982;1023-1032.
4. Bell I.R., Edman J.S., Marby D.W., Satlin A., Dreier T., Liptzin B., Cole J.O. Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol. Psychiatry. 27:1990;125-137.
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
6. Blount B.C., Ames B.N. DNA damage in folate deficiency. Baillieres Clin. Haematol. 8:1995;461-478.
7. Blundell G., Jones B.G., Rose F.A., Tudball N. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis. 122:1996;163-172.
8. Botez M.I., Young S.N., Bachevalier J., Gauthier S. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann. Neurol. 12:1982;479-484.
9. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr. Rev. 54:1996;382-390.
10. Bottiglieri T., Laundy M., Crellin R., Toone B.K., Carney M.W., Reynolds E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry. 69:2000;228-232.
11. Boutell J.M., Wood J.D., Harper P.S., Jones A.L. Huntingtin interacts with cystathionine beta-synthase. Hum. Mol. Genet. 7:1998;371-378.
12. Brattstrom L., Lindgren A., Israelsson B., Malinow M.R., Norrving B., Upson B., Hamfelt A. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur. J. Clin. Invest. 22:1992;214-221.
13. Brattstrom L., Lindgren A., Israelsson B., Andersson A., Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle aged and elderly subjects. J. Intern. Med. 236:1994;633-641.
14. Bunout D., Garrido A., Suazo M., Kauffman R., Venegas P., de la Maza P., Petermann M., Hirsch S. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition. 16:2000;107-110.
15. Buysschaert M., Dramais A.S., Wallemacq P.E., Hermans M.P. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diab. Care. 23:2000;1816-1822.
16. Cardo E., Monros E., Colome C., Artuch R., Campistol J., Pineda M., Vilaseca M.A. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J. Child Neurol. 15:2000;295-298.
17. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., Kooner J.S. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 102:2000;2479-2483.
18. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58:1999;167-190.
19. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., Chen M.F., Pai A., John S.W., Smith R.S., Bottiglieri T., Bagley P., Selhub J., Rudnicki M.A., James S.J., Rozen R. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10:2001;433-443.
20. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55:1998;1449-1455.
21. Coppola A., Davi G., De Stefano V., Mancini F.P., Cerbone A.M., Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin. Thromb. Hemost. 26:2000;243-254.
22. Cravo M.L., Camilo M.E. Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status. Nutrition. 16:2000;296-302.
23. Deloughery T.G., Evans A., Sadeghi A., McWilliams J., Henner W.D., Taylor L.M. Jr, Press R.D. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation. 94:1996;3074-3078.
24. DeRose D.J., Charles-Marcel Z.L., Jamison J.M., Muscat J.E., Braman M.A., McLane G.D., Keith-Mullen J. Vegan diet-based lifestyle program rapidly lowers homocysteine levels. Prev. Med. 30:2000;225-233.
25. Duan W., Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57:1999;195-206.
26. Duan W., Zhang Z., Gash D.M., Mattson M.P. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Ann. Neurol. 46:1999;587-597.
27. Duan, W., Ladenheim, B., Cutler, R.G., Cadet, J.L., Mattson, M.P., 2001. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem., in press.
28. Durand P., Frost M., Loreau N., Lussier-Cacan S., Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab. Invest. 81:2001;645-672.
29. Duthie S.J., Grant G., Narayanan S. Increased uracil misincorporation in lymphocytes from folate-deficient rats. Br. J. Cancer. 83:2000;1532-1537.
30. Freeman J.M., Finkelstein J.D., Mudd S.H. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. New Engl. J. Med. 292:1975;491-496.
31. Giles W.H., Croft J.B., Greenlund K.J., Ford E.S., Kittner S.J. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke. 29:1998;2473-2477.
32. Girelli D., Friso S., Trabetti E., Olivieri O., Russo C., Pessotto R., Faccini G., Pignatti P.F., Mazzucco A., Corrocher R. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood. 91:1999;4158-4163.
33. Glynn S.A., Albanes D., Pietinen P., Brown C.C., Rautalahti M., Tangrea J.A., Gunter E.W., Barrett M.J., Virtamo J., Taylor P.R. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol. Biomarkers Prev. 5:1996;487-494.
34. Godfrey P.S., Toone B.K., Carney M.W., Flynn T.G., Bottiglieri T., Laundy M., Chanarin I., Reynolds E.H. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 336:1990;392-395.
35. Graham I.M., O'Callaghan F. The role of folic acid in the prevention of cardiovascular disease. Curr. Opin. Lipidol. 11:2000;577-587.
36. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice. Nat. Med. 5:1999;101-107.
37. Hanratty C.G., McGrath L.T., McAuley D.F., Young I.S., Johnston G.D. The effects of oral methionine and homocysteine on endothelial function. Heart. 85:2001;326-330.
38. Hernanz A., Plaza A., Martin-Mola E., De Miguel E. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clin. Biochem. 32:1999;65-70.
39. Herran A., Garcia-Unzueta M.T., Amado J.A., Lopez-Cordovilla J.J., Diez-Manrique J.F., Vazquez-Barquero J.L. Folate levels in psychiatric outpatients. Psychiatry Clin. Neurosci. 53:1999;531-533.
40. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran L.J. Jr, Kohl B., Rao V., Kisiel W., Stern D.M., Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107:2001;675-683.
41. Holven K.B., Holm T., Aukrust P., Christensen B., Kjekshus J., Andreassen A.K., Gullestad L., Hagve T.A., Svilaas A., Ose L., Nenseter M.S. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am. J. Med. 110:2001;536-542.
42. Hsiao K. Transgenic mice expressing Alzheimer amyloid precursor proteins. Exp. Gerontol. 33:1998;883-889.
43. Hultberg B., Andersson A., Lindgren A. Marginal folate deficiency as a possible cause of hyperhomocystinaemia in stroke patients. Eur. J. Clin. Chem. Clin. Biochem. 35:1997;25-28.
44. Hultberg B., Andersson A., Isaksson A. Hypomethylation as a cause of homocysteine-induced cell damage in human cell lines. Toxicology. 147:2000;69-75.
45. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., Akhmedkhanov A., Zeleniuch-Jacquotte A., Riboli E. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br. J. Cancer. 79:1999;1917-1922.
46. Khajuria A., Houston D.S. Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood. 96:2000;966-972.
47. Kim Y.I. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr. Rev. 58:2000;205-209.
48. Kim Y.I., Shirwadkar S., Choi S.W., Puchyr M., Wang Y., Mason J.B. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology. 119:2000;151-161.
49. Kluijtmans L.A., Whitehead A.S. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur. Heart J. 22:2001;294-299.
50. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20:2000;6920-6926.
51. Kruman, I.I., Kumaravel, T.S., Lohani, A., Cutler, R.G., Kruman, Y., Haughey, N., Pedersen, W.A., Evans, M.K., Mattson, M.P., 2001. Folate deficiency and homocysteine enhance amyloid toxicity by impairing DNA repair, Soc. Neurosci. Abstr. 31, 962.9.
52. Kubova H., Folbergrova J., Mares P. Seizures induced by homocysteine in rats during ontogenesis. Epilepsia. 36:1995;750-756.
53. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A., Buttner T., Woitalla D., Muller T. Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40:1998;225-227.
54. Lalouschek W., Aull S., Serles W., Schnider P., Mannhalter C., Lang T., Deecke L., Zeiler K. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J. Lab. Clin. Med. 133:1999;575-582.
55. Langston J.W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44:1998;S45-52.
56. Lashner B.A., Heidenreich P.A., Su G.L., Kane S.V., Hanauer S.B. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology. 97:1989;255-259.
57. Lentz S.R., Erger R.A., Dayal S., Maeda N., Malinow M.R., Heistad D.D., Faraci F.M. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H970-975.
58. Levitt A.J., Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatry Scand. 86:1992;301-305.
59. Li J.C., Kaminskas E. Deficient repair of DNA lesions in Alzheimer's disease fibroblasts. Biochem. Biophys. Res. Commun. 129:1985;733-738.
60. Marsden C.D. Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;672-681.
61. Matsuo K., Suzuki R., Hamajima N., Ogura M., Kagami Y., Taji H., Kondoh E., Maeda S., Asakura S., Kaba S., Nakamura S., Seto M., Morishima Y., Tajima K. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 97:2001;3205-3209.
62. Mattson M.P. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
63. Mercie P., Garnier O., Lascoste L., Renard M., Closse C., Durrieu F., Marit G., Boisseau R.M., Belloc F. Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis. 5:2000;403-411.
64. Miller J.W. Homocysteine and Alzheimer's disease. Nutr. Rev. 57:1999;126-129.
65. Morita H., Kurihara H., Tsubaki S., Sugiyama T., Hamada C., Kurihara Y., Shindo T., Oh-hashi Y., Kitamura K., Yazaki Y. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler. Thromb. Vasc. Biol. 18:1998;1465-1469.
66. Morita H., Kurihara H., Yoshida S., Saito Y., Shindo T., Oh-Hashi Y., Kurihara Y., Yazaki Y., Nagai R. Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation. 103:2001;133-139.
67. Nagai Y., Tasaki H., Takatsu H., Nihei S., Yamashita K., Toyokawa T., Nakashima Y. Homocysteine inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 281:2001;726-731.
68. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23:1999;228-232.
69. Pogribny I.P., Basnakian A.G., Miller B.J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res. 55:1995;1894-1901.
70. Ravaglia G., Forti P., Maioli F., Vettori C., Grossi G., Bargossi A.M., Caldarera M., Franceschi C., Facchini A., Mariani E., Cavalli G. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech. Ageing Dev. 121:2000;251-261.
71. Regland B., Johansson B.V., Grenfeldt B., Hjelmgren L.T., Medhus M. Homocysteinemia is a common feature of schizophrenia. J. Neural Transm. Gen. Sect. 100:1995;165-169.
72. Regland B., Germgard T., Gottfries C.G., Grenfeldt B., Koch-Schmidt A.C. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J. Neural Transm. 104:1997;931-941.
73. Reynolds E.H., Preece J.M., Bailey J., Coppen A. Folate deficiency in depressive illness. Br. J. Psychiatry. 117:1970;287-292.
74. Robison S.H., Munzer J.S., Tandan R., Bradley W.G. Alzheimer's disease cells exhibit defective repair of alkylating agent-induced DNA damage. Ann. Neurol. 21:1987;250-258.
75. Roubenoff R., Dellaripa P., Nadeau M.R., Abad L.W., Muldoon B.A., Selhub J., Rosenberg I.H. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum. 40:1997;718-722.
76. Saw S.M., Yuan J.M., Ong C.N., Arakawa K., Lee H.P., Coetzee G.A., Yu M.C. Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am. J. Clin. Nutr. 73:2001;232-239.
77. Scott J.M., Weir D.G. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J. Cardiovasc. Risk. 5:1998;223-227.
78. Schwaninger M., Ringleb P., Winter R., Kohl B., Fiehn W., Rieser P.A., Walter-Sack I. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia. 40:1999;345-350.
79. Selhub J., Bagley L.C., Miller J., Rosenberg I.H. B vitamins, homocysteine, and neurocognitive function in the elderly. Am. J. Clin. Nutr. 71:2000;614S-620S.
80. Shields D.C., Kirke P.N., Mills J.L., Ramsbottom D., Molloy A.M., Burke H., Weir D.G., Scott J.M., Whitehead A.S. The thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64:1999;1045-1055.
81. Sirotnak F.M., Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19:1999;91-122.
82. Smithells R.W., Sheppard S., Schorah C.J. Vitamin deficiencies and neural tube defects. Arch. Dis. Child. 51:1976;944-950.
83. Snowdon D.A., Tully C.L., Smith C.D., Riley K.P., Markesbery W.R. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am. J. Clin. Nutr. 71:2000;993-998.
84. Song J., Sohn K.J., Medline A., Ash C., Gallinger S., Kim Y.I. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/- Msh2-/- mice. Cancer Res. 60:2000;3191-3199.
85. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
86. Sung F.L., Slow Y.L., Wang G., Lynn E.G., Karmin O. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol. Cell. Biochem. 216:2001;121-128.
87. Surtees R., Bowron A., Leonard J. Cerebrospinal fluid and plasma total homocysteine and related metabolites in children with cystathionine β-synthase deficiency: the effect of treatment. Pediatr. Res. 42:1997;577-582.
88. Susser E., Brown A.S., Klonowski E., Allen R.H., Lindenbaum J. Schizophrenia and impaired homocysteine metabolism: a possible association. Biol. Psychiatry. 44:1998;141-143.
89. Tseng M., Murray S.C., Kupper L.L., Sandler R.S. Micronutrients and the risk of colorectal adenomas. Am. J. Epidemiol. 144:1996;1005-1014.
90. Verhoeff B.J., Trip M.D., Prins M.H., Kastelein J.J., Reitsma P.H. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis. 141:1998;161-166.
91. Wainfan E., Poirier L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 52:1992;2071-2077.
92. Wall R.T., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18:1980;113-121.
93. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., Zhou J., Maeda N., Krisans S.K., Malinow M.R., Austin R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107:2001;1263-1273.
94. Wu K., Helzlsouer K.J., Comstock G.W., Hoffman S.C., Nadeau M.R., Selhub J. A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol. Biomarkers Prev. 8:1999;209-217.
95. Yasui K., Kowa H., Nakaso K., Takeshima T., Nakashima K. Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology. 55:2000;437-440.
96. Yoshino Y. Possible involvement of folate cycle in the pathogenesis of amyotrophic lateral sclerosis. Neurochem. Res. 9:1984;387-391.
97. Yu Z.F., Luo H., Fu W., Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155:1999;302-314.